Funding AMR research: the UK Research Councils John Savill
|
|
- Mark Hoover
- 6 years ago
- Views:
Transcription
1 Funding AMR research: the UK Research Councils John Savill Medical Research Council - UK
2 MRC mission Encourage and support high-quality research with the aim of improving human health. Produce skilled researchers. Advance and disseminate knowledge and technology to improve the quality of life and economic competitiveness in the UK and worldwide. Promote dialogue with the public about medical research.
3 MRC investment in research, 2012/13 MRC research expenditure million in 2012/ m on around 400 programmes in MRC research units and institutes (inc 9.9m on studentships) m on around 1,400 grants to researchers in universities, medical schools and research institutes. 86.1m on studentships and fellowships in universities, medical schools and research institutes.
4 The UK: A rich network of funders and researchers Research community UK Clinical Research Collaboration Learned societies UK Government Departments OSCHR Research Councils NIHR Technology Strategy Board Public Parliamentarians Policy-makers Industry Universities DEFRA International Medical charities Patients and carers NHS
5 AMR research in the UK Growing concern of AMR: a political and societal priority The research councils: broad remits; support AMR across the whole of the research spectrum Research Councils portfolio: ~ 30m per year on AMR
6 What is needed? Collaborative working Coordination of key disciplines Coordinating research funding government and other research funders including industry Ensuring integration with human/animal healthcare UK AMR Funders Forum
7 AMR Funders Forum (AMRFF) Made up of representatives from the research councils, governmental bodies and charities Led and managed by the MRC Has a common vision for AMR research and its implementation Will add value to existing programmes Will coordinate and/or support the initiation of funding and delivery programmes Will raise the profile of the AMR research base in the UK and internationally
8 AMRFF current membership The Biotechnology and Biological Sciences Research Council (BBSRC) DEFRA, the Veterinary Medicines Directorate The Department of Health The Economic and Social Research Council (ESRC) The Engineering and Physical Sciences Research Council (EPSRC) The Food Standards Agency HSC R&D Division, Public Health Agency, Northern Ireland *The Medical Research Council (MRC) National Institute of Health Research (NIHR) The Natural Environment Research Council (NERC) The Science and Technology Facilities Research Council (STFC) The Technology Strategy Board (TSB) The Wellcome Trust
9 Research priorities identified Understanding resistant bacteria in context: from genomic, through to cellular and host pathogen interaction Accelerating therapeutic and diagnostics development: development and revisiting of small molecule antibiotics, new non-small molecule based treatments and diagnostics Understanding real world interactions: how resistant bacteria affect their environments and vice versa. New sources of antibiotics Behaviour and care: behaviour change in human and animal healthcare settings. New business models needed for antibiotics development
10 UK spend on AMR (since 2007) Total funding: 337m Therapeutics 0.6m 26.6m Diagnostics 20.4m Surveillance Transmission Environment 20.6m 68.7m 200m Underpinning Alternatives Optimisation Lead compounds Interventions
11 The breadth of current research Major UK investments: Understanding bacteria: Eg: Centre for Molecular Bacteriology and Infection Technology to reduce infection: Eg: Early Warning Sensing Systems i-sense (EPSRC) Links with industry: Eg: New anti-bacterial to treat MRSA (BBSRC) Environment: Eg: NERC Centre for Ecology and Hydrology: modelling antibiotics usage
12 Current joint initiatives 4 x UKCRC Translational Infection Research Initiative consortia, MRC-led joint initiative University of Oxford, Derrick Crook (genomics to detect transmission) Imperial, Jonathan Friedland (Health Care Associated Infection and AMR) University of Cambridge, Sharon Peacock (MRSA transmission) University of London, Tariq Sadiq (Diagnostics and STIs) Environmental and Social Ecology of Human Infectious Diseases (ESEI) MRC-led, as part of LWEC novel inter-disciplinary approaches to studying the ecology of infectious diseases
13 Cambridge UKCRC Consortium UK MRSA investigation network: a case study English referral network : Donker, Wallinga and Grundmann, PLoS 2012
14 Case study outcomes Whole genome sequencing tools to detect patterns of MRSA transmission Transmission modelling within a hospital and between hospitals UK hospital: Addenbrooke Cambridge Netherlands hospital: University Medical hospital Groningen MRSA rate reflects connectivity of the hospital more movement and referral between hospitals, less control of MRSA Hospitals that share >50 patients / year share homogenous MRSA
15 Developing international links - highlights JPIAMR: MRC lead on behalf of the UK Canada: 2 x UK-CIHR Partnership on antimicrobial resistance consortia University of Cardiff (Tim Walsh) and Canada (Gary Dmitrienko) University of Warwick (Chris Dowson) and Canada (Anthony Clarke) BBSRC partner of Global Strategic Alliance for coordination of research on major infectious diseases of animals and zoonoses Currently identifying international opportunities via RCUK offices in China, India and USA
16 Providing excellent underpinning resources Medical Bioinformatics call Universities of Warwick and Swansea: The MRC Consortium for Medical Microbial Bioinformatics (wide range of research including AMR surveillance and data sharing) The Farr Institute: for health informatics research Linking with Industry IMI: the MRC represents the UK Revisiting old compounds with new science TSB/MRC Biomedical Catalyst fund Eg: The use of light activated antimicrobials to prevent catheter related infection. Ivan Parkin, UCL
17 The next steps Develop new research opportunities Academic/private sector International Develop new treatments Develop new diagnostics Develop surveillance systems Uptake by human/animal healthcare providers
Strategic priority for AMR
Strategic priority for AMR Transforming our response to drug resistant infections Ghada Zoubiane PhD Science Lead Drug-Resistant Infections priority programme Joint Programming Initiative on AMR MB meeting
More informationResearch and development case study. Human health research
Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationHealthcare Technologies Strategy
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Healthcare Technologies Strategy TOWN MEETING, APRIL 14 th 2015 Aug 2014 Engineering and Physical Sciences Research Council Healthcare Technologies 29%of
More informationAMR and EPSRC AMR Networks Meeting, Sheffield, Sept 16 Christina Turner and Stephanie Newland
AMR and EPSRC AMR Networks Meeting, Sheffield, Sept 16 Christina Turner and Stephanie Newland Overview AMR at RCUK and EPSRC Annual Monitoring Funding RCUK AMR Initiative Unless we take global action,
More informationMRC s Pathways to Translation.. Louise Jones, Feb 13 th 2015, LSTM
MRC s Pathways to Translation.. Louise Jones, Feb 13 th 2015, LSTM MRC Remit and Partners MRC: basic research to early clinical trials Underpinning and aetiological Prevention Detection and diagnosis Treatment
More informationMRC Translational Funding
MRC Translational Funding Dr Jo Latimer- 29 February 2016 Medical Research Council MRC: Leading & Partnering Research Dedicated to improving human health through the best scientific research. Established
More informationRoyal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance
Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance The Royal Society of Chemistry is the world s leading chemistry
More informationUK AMR Diagnostics Collaborative:
UK AMR Diagnostics Collaborative: Maximising the use of diagnostic technology to tackle AMR Fiona Carragher FRCPath @DepCSOFiona Deputy Chief Scientific Officer for England england.amrdiagnostics@nhs.net
More informationEnabling the adoption of new diagnostics within the UK healthcare system:
Enabling the adoption of new diagnostics within the UK healthcare system: The key role of diagnostics in the AMR challenge Fiona Carragher FRCPath @DepCSOFiona Deputy Chief Scientific Officer for England
More informationThe role of PHE s AMRHAI Reference Unit
The role of PHE s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright What does AMRHAI offer? Susceptibility
More informationThe Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle
The Wellcome Trust Research Support and Strategy in Epidemiology Monday, 22 September 2008 Dr Alan Doyle The Wellcome Trust an independent researchfunding charity established 1936 funded from private endowment
More informationResearch Councils UK Energy Programme
Research Councils UK Energy Programme Kathryn Magnay, Head RCUK Energy Programme For a Low Carbon Energy Future The Research Councils Research Councils UK (RCUK) are responsible for investing public money
More informationMRC Stratified Medicine Initiative
MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified
More informationImproving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre
Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating
More informationBIOMEDICAL RESEARCH CENTRES
Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationMINUTES. UK CLINICAL RESEARCH COLLABORATION BOARD MEETING 14 May 2015
MINUTES UK CLINICAL RESEARCH COLLABORATION BOARD MEETING 14 May 2015 Present Members Minutes of the meeting held on 14 May 2015, Rooms 1&2, 13th Floor, MRC, One Kemble Street, London WC2B 4TS Sir John
More informationA new vision for AMR innovation to support medical care
APRIL 2019 A new vision for AMR innovation to support medical care About the BEAM Alliance The BEAM Alliance (Biotech companies from Europe innovating in Anti-Microbial resistance research) represents
More informationResearch Councils UK Energy Programme
Research Councils UK Energy Programme For a Low Carbon Energy Future Jason Green Treasury ETI BIS TSB RCUK AHRC BBSRC ESRC EPSRC MRC NERC STFC Cross Council Energy Programme Treasury ETI BIS TSB RCUK AHRC
More informationNIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health
NIHR at 10: Wessex Professor Chris Whitty Chief Scientific Adviser Department of Health Building on 10 remarkable years The extraordinary advances in health are based on evidence and science, properly
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationAntimicrobial Drug Discovery
Antimicrobial Drug Discovery Following publication of the Statement Antimicrobial drug discovery: greater steps ahead (http://www.easac.eu/home/reports and statements/detailview/article/antimicrobia.html),
More informationThe Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe
The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe Innovate UK and ATMP background 1. Innovate UK is the
More informationTRANSLATIONAL RESEARCH PARTNERSHIPS
TRANSLATIONAL RESEARCH PARTNERSHIPS Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. NIHR Translational Research
More informationDelivering the NIHR Central Commissioning Facility
Delivering the NIHR Central Commissioning Facility About the NIHR The National Institute for Health Research is funded through the Department of Health to improve the health and wealth of the nation through
More informationA whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger
A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.
More informationResearch Councils UK Energy Programme
Research Councils UK Energy Programme Valuing Natural Capital in Low Carbon Energy Pathways Programme - Ideas Brokerage Workshop 21 st - 22 nd July 2014 Eloise Meller, ESRC For a Low Carbon Energy Future
More informationUK Molecular Pathology Landscape
UK Molecular Pathology Landscape Jonathan Pearce Medical Research Council, Translational Programme Manager Novel Markers and Technology: 12 October 2015 Stratified medicine has the potential to deliver
More informationLongitudinal Population Studies Strategy
Longitudinal Population Studies Strategy Wellcome s Longitudinal Population Studies Working Group July 2017 Executive summary Opportunity Longitudinal population studies (LPS), which include cohorts, panel
More informationBiomedical & Health Research (BHR) Strategy
Biomedical & Health Research (BHR) Strategy Vision To be internationally recognised for our research in Biomedicine and Health, addressing global grand challenges through distinctive, focussed, world-leading
More informationLEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE
LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION S STRENGTHS: LIFE SCIENCES - THE OPPORTUNITY TAP INTO WORLD-LEADING RESEARCH FROM LEEDS CITY REGION S UNIVERSITIES ACCELERATING
More informationCancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure. June 2013
Cancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure June 2013 1. Every year around 300,000 people are diagnosed with cancer in the UK.
More informationResearch Strategy Delivering internationally excellent research for a healthy, safe and sustainable society
Research Strategy 2016-2018 Delivering internationally excellent research for a healthy, safe and sustainable society Mission The College of Biomedical and Life Sciences aims to deliver internationally
More informationThe Innovative Medicines Initiative Europe s partnership for health. Tek-Ang LIM, 20 June 2018, Brussels
The Innovative Medicines Initiative Europe s partnership for health Tek-Ang LIM, 20 June 2018, Brussels 10 YEARS OF LIGHTING THE WAY IMI Why Europe s partnership for health? Because despite decades of
More informationNIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE
NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE EXPERTISE AND CAPABILITIES The TRC in Inflammatory Respiratory Disease provides cutting-edge expertise in the development of exploratory
More informationMedicines for Children Research Network. Consumer Strategy
Medicines for Children Research Network Consumer Strategy 2012-2015 NIHR-MCRN Strategy for Consumer Involvement 2012-2015 1. Introduction and background Consumer involvement is a central thread running
More informationArticles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY.
Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis Ruth Kelly, Ghada Zoubiane,
More informationTheme 2 Workshop: Accelerating therapeutic and diagnostics development
Theme 2 Workshop: Accelerating therapeutic and diagnostics development Workshop Report... 2 1. Background... 2 2. Format of the Workshops... 2 3. Workshop presentations... 3 4. Breakout sessions and group
More informationAustralian Medical Research and Innovation Priorities Determination 2018
Australian Medical Research and Innovation Priorities 2018 2020 Determination 2018 I, Ian Frazer, Chair of the Australian Medical Research Advisory Board, make the following instrument on behalf of the
More informationThe Impact of Translational Research
The Impact of Translational Research Chris Watkins and Ian Viney Medical Research Council October 2016 Open Council Translation Across the MRC Portfolio MRC support for translational medicine Proportion
More informationSustainable Health Care Systems: Research and Innovation
Backgroundpaper B7-Communiqué Sustainable Health Care Systems: Research and Innovation Version II BDI, BUSINESSEUROPE Canadian Chamber of Commerce CBI CONFIDUSTRIA Keidanren MEDEF US Chamber of Commerce
More information1.0 Background to the organisation
1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationSummary of MRC Unit and Institute Quinquennial Reviews
Summary of MRC Unit and Institute Quinquennial Reviews The MRC carries out scientific reviews in order to be assured of: the overall quality, impact, and productivity (past and future potential) of the
More informationMed-tech and diagnostic device pathways in Newcastle
Med-tech and diagnostic device pathways in Newcastle Andrew Sims Medical Physics Newcastle upon Tyne Hospitals NHS Foundation Trust 12/07/2016 AHSN Stakeholder Engagement Meeting 1 Introduction Section
More informationMeeting Opening MRC Molecular Pathology Review NIHR support for molecular pathology Innovate UK Precision Medicine Catapult
Agenda Agenda 10:30 Meeting Opening 10:40 MRC Molecular Pathology Review Professor Sir Robert Lechler (King s College London and Chair of Review Steering Group) 10:55 NIHR support for molecular pathology
More informationResearch Councils UK. The Future of RCUK/ EPSRC Research Funding. Dr Clive Hayter, Associate Director Research Programmes, EPSRC
Research Councils UK The Future of RCUK/ EPSRC Research Funding Dr Clive Hayter, Associate Director Research Programmes, EPSRC Spending Review Allocation (1) Spending Review covers the period 2011/12 2014/15
More informationMoving towards delivering precision medicine in sepsis
Moving towards delivering precision medicine in sepsis Paul Dark Professor of Critical Care Medicine, Division of Infection and Immunity, University of Manchester NIHR CRN National Specialty Lead (Critical
More informationTo identify the key research questions in greenhouse gas removal from the atmosphere in the remits of the organising bodies.
Greenhouse Gas Removal from the Atmosphere 1. Announcement of Workshop London, 28 April 2016 The deadline for applications is 16:00 on Monday 11 th April 2016. Applications received after this time will
More informationConference Exhibitors
Conference Exhibitors CSM Executive and the 2018 Manitoba Local Organizing Committee would like to thank the following organizations for exhibiting and supporting the Canadian Society of Microbiologists
More informationThe International Consortium for Personalised Medicine
The International Consortium for Personalised Medicine Mairead O Driscoll Alliance for Biomedical Research in Europe, 8 November 2017 Personalised Medicine A definition Characterisation of individuals
More informationUniversity of Cambridge Wellcome Trust. Senior Internships for Interdisciplinary Research
University of Cambridge Wellcome Trust Senior Internships for Interdisciplinary Research Introduction and aims of the Scheme Applications are invited for the next round of University of Cambridge Wellcome
More informationAcademic Medical Bacteriology A 2/7/01 2:40 pm Page 3. Academic Medical Bacteriology in the 21st Century
Academic Medical Bacteriology A 2/7/01 2:40 pm Page 3 Academic Medical Bacteriology in the 21st Century July 2001 The Academy of Medical Sciences The Academy of Medical Sciences was established in 1998
More informationECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)
ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT
More informationA2 Drive new ways of working, especially data-intensive/rich, multidisciplinary bioscience (2.1.2)
A: BBSRC sustaining world class bioscience in the UK - maintaining excellence in bioscience A1 Continue to fund highest quality, Help retain UK s world-leading position fundamental bioscience (Pervasive)
More informationLONG-TERM BENEFITS FROM RESEARCH INTO STREPTOMYCES BACTERIA
LONG-TERM BENEFITS FROM RESEARCH INTO STREPTOMYCES BACTERIA Many of the most important antibiotics used in hospitals around the world come from Streptomyces bacteria. Recent discoveries have shown that
More informationThe NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network
The NIHR NIHR: health research in 2030 Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London Why? https://www.bhf.org.uk/publications/statistics/ trends-in-coronary-heart-disease-1961-2011
More informationRare diseases in the 7th EU Framework Programme for Research and Technological Development
Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of
More informationSSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview
SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy
More informationGlobal Antibiotic R&D Partnership A joint WHO/DNDi initiative. Overview. Dr Manica Balasegaram GARDP Director
Global Antibiotic R&D Partnership A joint WHO/DNDi initiative Overview Dr Manica Balasegaram GARDP Director What is GARDP? The Global Antibiotic Research and Development Partnership is a not-for-profit
More informationSupporting efficient and effective clinical research in the UK
Supporting efficient and effective clinical research in the UK National Institute for Health Research 10 years of delivering health and care research for the nation HRB CRCI Launch Dr Matthew Hallsworth
More informationThe Genomic Transformation of Health
The Genomic Transformation of Health or: an introduction to the potential of genomics in healthcare Dr Tom Connor School of Biosciences and Systems Immunity University Research Institute Cardiff University
More informationBEAM Alliance urges G20 support to fight deadly superbugs
Press Release BEAM Alliance urges G20 support to fight deadly superbugs At the Hamburg G20 summit, political leaders will speak about a growing global health threat - antibiotic resistance - which causes
More informationInternational Cooperation in Health Research and Life Sciences Modalities and Topics of next Call
1 International Cooperation in Health Research and Life Sciences Modalities and Topics of next Call Dr Gianpietro van de Goor Directorate Health, DG Research European Commission Open Information Day Brussels,
More information2016 EUROPE NORDIC U.S. SYMPOSIUM. New Frontiers in Antibacterial Resistance Research
2016 EUROPE NORDIC U.S. SYMPOSIUM New Frontiers in Antibacterial Resistance Research January 20-21, 2016 Venue: Karolinska institutet Stockholm, Sweden Objectives: Antibacterial resistance is accelerating
More informationAppointment of: Programme leaders for the UK Dementia Research Institute
Appointment of: Programme leaders for the UK Dementia Research Institute Contents 3 About the UK Dementia Research Institute 4 Strategic vision 6 About the centres 8 Programme leader profile - UK DRI Professor
More informationCONSTITUTION OF THE GLOBAL ALLIANCE FOR GENOMICS AND HEALTH. Adopted, 2014
CONSTITUTION OF THE GLOBAL ALLIANCE FOR GENOMICS AND HEALTH Adopted, 2014 This Constitution sets forth the mission, objectives, and structure of the Global Alliance for Genomics and Health (Global Alliance).
More informationRussell Group input to the 2013 Triennial Review of the Research Councils
Russell Group input to the 2013 Triennial Review of the Research Councils Summary The broad objectives for the Research Councils remain highly relevant and still need to be delivered. Any significant disruption
More informationWHO draft outline of global action plan on antimicrobial resistance
WHO draft outline of global action plan on antimicrobial resistance Response by the Wellcome Trust Key Points Antimicrobial resistance (AMR) is a global health crisis which no government can tackle on
More informationDiagnostics gathering intelligence to fight antimicrobial resistance
Diagnostics gathering intelligence to fight antimicrobial resistance Arjon van Hengel European Commission DG Research and Innovation, Health Directorate Unit "Fighting Infectious Diseases and Advancing
More informationCourse outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006
Course outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006 These course outlines are a guide only. They are provided for the
More informationIndependent Member of the HMG Strategic Coherence of ODA-funded Research (SCOR) Board. Information pack for applicants
Independent Member of the HMG Strategic Coherence of ODA-funded Research (SCOR) Board Closing date for applications: 2nd of March 2018 Information pack for applicants Applications processed by the UK Collaborative
More informationThe role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
in partnership with The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU) CTRad Clinical Trials Workshop 14/10/2014 What is
More informationState strategies for bioinformatics in BRICs and the UK. Professor Brian Salter
State strategies for bioinformatics in BRICs and the UK Professor Brian Salter This new facility is the embodiment of our investment in big data and bioinformatics. We are not only ensuring that people
More informationProgramme Manager GROW Colombia JOB VACANCY
Programme Manager GROW Colombia JOB VACANCY Job details Salary: 39,150-47,850 Post No: 1003398 Contract length: 46 months Department: Organisms & Ecosystems Opening date: 22 January 2018 Closing date:
More informationConsultation on a draft Global action plan to address antimicrobial resistance
Consultation on a draft Global action plan to address antimicrobial resistance The questionnaire is divided into four sections. The questions are broadly framed and intended to give you the opportunity
More informationUK Government Approach to Synthetic Biology. Adrian Smith DG Science and Research
UK Government Approach to Synthetic Biology Adrian Smith DG Science and Research UK Research Framework Funding approach is through arm s length agencies Government sets overall funding strategy Funding
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationIntroductory guide to understanding impact
Introductory guide to understanding impact MVLS impact vision MVLS believes that all excellent research can achieve impact making a constructive difference in some way and at some time, that will ultimately
More informationThe Wellcome Trust. FundERS rd Sept 2015
The Wellcome Trust FundERS 2015 23 rd Sept 2015 Introduction Our History The Wellcome Trust was set up in 1936 under the will of Sir Henry Wellcome, who vested the entire share of his pharmaceutical company,
More informationSupplementary Materials for
www.sciencetranslationalmedicine.org/cgi/content/full/6/242/242cm6/dc1 Supplementary Materials for Sandbox: Building and Sharing Resources This PDF file includes: Mark David Lim E-mail: mlim@fastercures.org
More informationMapping the Landscape of UK Health Data Research & Innovation
Mapping the Landscape of UK Health Data Research & Innovation A snapshot of activity in 2017 Dr Ekaterini Blaveri October 2017 CONTENTS Foreword 5 1. Background to this review 7 1.1. Aims 8 1.2. Scope
More informationFacilitating Antibacterial Drug Development Outlining the Path Forward
Facilitating Antibacterial Drug Development Outlining the Path Forward Helen Boucher, MD FIDSA FACP Division of Infectious Diseases and Geographic Medicine Tufts Medical Center Tufts University School
More informationEU support for Health Research from FP6 to FP7
EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes
More informationNordic Common Strengths and Future Potential in the Field of Personalised Medicine
Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research
More informationArticles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY.
Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis Ruth Kelly, Ghada Zoubiane,
More informationWebinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative
Webinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative 27.11.2017 15:00 CET Agenda How to use GoToWebinar Catherine Brett,
More informationScottish Microbiology & Virology Network (SMVN)
Scottish Microbiology & Virology Network (SMVN) Annual Workplan 2017-2018 Version 1.0 26 May 2017 Page 1 of 10 SMVN HIGH PRIORITY OVERVIEW The highest priority activities of the SMVN are summarised below.
More informationAntimicrobial resistance: environments, evolution and transmission. Workshop series summary
Antimicrobial resistance: environments, evolution and transmission Networking workshops for researchers Workshop series summary Charles Darwin House, London, 25 June 2015 Discovery Centre for Translational
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationInfectious Diseases Institute Faculty Hires See below for research interests, areas of expertise and contact information
Infectious Diseases Institute Faculty Hires See below for research interests, areas of expertise and contact information Matt Anderson, Ph.D. Anderson.3196@osu.edu Microbial Communities, Host Defense and
More informationLABORATORY TRAINING LOGBOOK
REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First
More informationCall Details. Introduction of DBT-BIRAC Joint call:
Call Details Antimicrobial resistance (AMR) is one of the major threats to human health in the 21 st century, with some bacterial pathogens acquiring resistance to all clinically available antibiotics.
More informationBOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.
Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS
More informationInnovative Medicines Initiative:
Innovative Medicines Initiative: Opportunities for local players to become important parts of multicountry pharma innovation Nathalie Serigneuret 4 March 2015 Clinical Trials Conference 2015, Budapest
More informationIllustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017
Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight Daria Iovcheva November, 2017 1 Contents 1.0 About Springer Nature and our platforms 2.0 Nature Research Journals:
More informationOur Research Strategy
Our Research Strategy 2014-2017 Introduction Kidney Research UK has a 52-year legacy in funding excellent research into all aspects of kidney diseases and disorders. Each year over 3.7 million 1 new investments
More informationThe interplay between AMR surveillance and science Report of JPIAMR workshop October 2016, The Research Council of Norway, Oslo, Norway
The interplay between AMR surveillance and science Report of JPIAMR workshop 12.-13. October 2016, The Research Council of Norway, Oslo, Norway Table of contents List of participants... 1 Abbreviations...
More informationEU Big Data Initiatives
European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives
More information